ArticleAnnals of medicine2025

Molecular features influencing clinical outcome of advanced HER2-positive gastric cancer receiving trastuzumab plus chemotherapy.

Yu Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.